Clinical Trial: REAL-WORLD OUTCOMES IN EPILEPSY PATIENTS WHO TRANSITIONED FROM LEVETIRACETAM MONOTHERAPY TO BRIVARACETAM MONOTHERAPY DUE TO INTOLERABLE ADVERSE DRUG REACTIONS: A PROSPECTIVE, NON-INTERVENTIONAL STUDY IN JAPAN (Japan)

Tokyo, Oct. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063262) titled 'A Prospective Observational Study Evaluating Outcomes in Patients with Epilepsy Switched from Levetiracetam Monotherapy to Brivaracetam Monotherapy Due to Adverse Drug Reaction' on Oct. 15.

Study Type: Observational

Primary Sponsor: Institute - UCB Biopharma SRL

Condition: Condition - Epilepsy Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the change from baseline at 12W in severity of adverse drug reactions to levetiracetam in patients who transitioned to brivaracetam monotherapy after discontinuation of levetiracetam monotherapy due to occurrence of...